Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial
© 2016 American College of Cardiology Foundation Objectives The study compared, by intravascular ultrasound (IVUS), acute gain (AG) at the site of the pre-procedural minimal lumen area (MLA) achieved by either the Absorb (Abbott Vascular, Santa Clara, California) scaffold or the Xience stent and ide...
Saved in:
Main Authors: | Yohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, Shimpei Nakatani, Yun Kyeong Cho, Maik J. Grundeken, Yaping Zeng, Hiroki Tateishi, Pieter C. Smits, Paul Barragan, Ran Kornowski, Anthony H. Gershlick, Stephan Windecker, Robert Jan van Geuns, Antonio L. Bartorelli, Robbert J. de Winter, Jan Tijssen, Patrick W. Serruys, Yoshinobu Onuma |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84994044884&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial
by: Sotomi Y., et al.
Published: (2017) -
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
by: Pannipa Suwannasom, et al.
Published: (2018) -
Relation between bioresorbable scaffold sizing using QCA-Dmax and clinical outcomes at 1 year in 1,232 patients from 3 study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
by: Yuki Ishibashi, et al.
Published: (2018) -
Relation between bioresorbable scaffold sizing using QCA-Dmax and clinical outcomes at 1 year in 1,232 patients from 3 study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
by: Yuki Ishibashi, et al.
Published: (2018) -
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
by: Yohei Sotomi, et al.
Published: (2018)